GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » WELL Health Technologies Corp (TSX:WELL) » Definitions » 3-Year RORE %

WELL Health Technologies (TSX:WELL) 3-Year RORE % : 325.40% (As of Sep. 2024)


View and export this data going back to 2012. Start your Free Trial

What is WELL Health Technologies 3-Year RORE %?

Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments. WELL Health Technologies's 3-Year RORE % for the quarter that ended in Sep. 2024 was 325.40%.

The industry rank for WELL Health Technologies's 3-Year RORE % or its related term are showing as below:

TSX:WELL's 3-Year RORE % is ranked better than
97.72% of 613 companies
in the Healthcare Providers & Services industry
Industry Median: -0.25 vs TSX:WELL: 325.40

WELL Health Technologies 3-Year RORE % Historical Data

The historical data trend for WELL Health Technologies's 3-Year RORE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

WELL Health Technologies 3-Year RORE % Chart

WELL Health Technologies Annual Data
Trend Oct14 Oct15 Oct16 Oct17 Oct18 Dec19 Dec20 Dec21 Dec22 Dec23
3-Year RORE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 42.86 -17.42 -

WELL Health Technologies Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
3-Year RORE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -41.45 - -298.25 189.39 325.40

Competitive Comparison of WELL Health Technologies's 3-Year RORE %

For the Medical Care Facilities subindustry, WELL Health Technologies's 3-Year RORE %, along with its competitors' market caps and 3-Year RORE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


WELL Health Technologies's 3-Year RORE % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, WELL Health Technologies's 3-Year RORE % distribution charts can be found below:

* The bar in red indicates where WELL Health Technologies's 3-Year RORE % falls into.



WELL Health Technologies 3-Year RORE % Calculation

WELL Health Technologies's 3-Year RORE % for the quarter that ended in Sep. 2024 is calculated as:

3-Year RORE %=( Most Recent EPS (Diluted)- First Period EPS (Diluted) )/( Cumulative EPS (Diluted) for 3-year -Cumulative Dividends per Share for 3-year )
=( 0.28--0.13 )/( 0.126-0 )
=0.41/0.126
=325.40 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of 3-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Sep. 2024 and 3-year before.


WELL Health Technologies  (TSX:WELL) 3-Year RORE % Explanation

Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.

There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 3-year period is chosen.

Be Aware

Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.


WELL Health Technologies 3-Year RORE % Related Terms

Thank you for viewing the detailed overview of WELL Health Technologies's 3-Year RORE % provided by GuruFocus.com. Please click on the following links to see related term pages.


WELL Health Technologies Business Description

Traded in Other Exchanges
Address
375 Water Street, Suite 550, Vancouver, BC, CAN, V6B 5C6
WELL Health Technologies Corp is a practitioner-focused digital healthcare company. It has seven reportable segments that are grouped into three key business units: Canadian Patient Services that includes Primary and Specialized MyHealth. WELL Health USA Patient Services includes Primary Circle Medica, Primary WISP, Specialized CRH Medical, and Specialized Provider Staffing and SaaS and Technology Services. It generates the majority of its revenue from Well Health USA Patient and Provider Services unit.
Executives
Eva Fong Senior Officer
Hamed Shahbazi 10% Security Holder, Director, Senior Officer
John Kim Director
Amir Javidan Senior Officer
Thomas Craig Liston Director
Tara Mccarville Director
Kenneth Anthony Cawkell Director
Sybil E Jen Lau Director
Well Health Technologies Corp. Issuer
Arjun Kumar Senior Officer
Brian Eric Levinkind Director

WELL Health Technologies Headlines